Automated lipid nanoparticle production could accelerate the development of RNA therapies
RNA vaccines and other nucleic acid therapeutics are typically packaged within fatty molecules known as lipid nanoparticles (LNPs). MIT researchers have now developed a way to produce these particles much more quickly and with more precise control over their size and shape.
RNA vaccines and other nucleic acid therapeutics are typically packaged within fatty molecules known as lipid nanoparticles (LNPs). MIT researchers have now developed a way to produce these particles much more quickly and with more precise control over their size and shape. This story matters for Science & Discovery readers tracking science. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. LearningWire.com curates and briefs the science & discovery stories that matter. Our editorial policy →
Get the daily science & discovery signal